Jack is not a skilled orator, the should have someone else on the show representing ARNA. If he wants to announce a buy out for $14, that would be OK.
Kadcyla sales could reach 6.8BB by 2020. Let's just hope IMGN is not still a public company then.
12.500 options is a bit generous for a BOD seat. If the stock just goes back to just the level where they did the offering a few months ago, these Directors make almost $100K for attending a few meetings. It's a bit much IMO, but standard for the over-compensated biotech industry. Directors and execs always eat first and leave the scraps for retail.
shorts are fighting it hard, SGEN has been up big the past 2 days, IMGN held back, or no buying interest, hard to say.
BOD needs to wake up!
first they need to upgrade, or improve it. In the current form it has already proven to be more toxic than good. I would think they could apply learning from the past several years since the drug was developed to make it more effective, or less toxic, assuming they have the time and there's a value proposition, ROI, etc.
I have he solution
1) Fire Junius
2) Hire an investment banking firm to get the best price for the shareholder owners
3) Do it now before shareholders take legal action against the absent BOD and worthless/ harmful/ shameless/ greedy CEO. Hit the road Dan, your time is up! You should be ashamed at the damage you have causesd and continue to cause to shareholder value and the shareholders that OWN IMGN. The company is worth $20+ NOW in a sale and that's what we demand! $12 is unacceptable.
I see what you are saying needs to break 12.37 to complete the right shoulder and break out. Possible upside looks like about $14 as a possible resting spot. IDIX should have the Bio-shorts very nervous.
$7 to $24 overnight. IMGN can certainly go from $12 to $20+ if someone takes action to unlock the value. This deal will put more pressure on IMGN management to rapidly increase the stock price IMO.
I agree possible investigation sounds weak and the problem is that they have allowed this type of article filled with half truths by their own foolish actions. I don't think much will come from this, but the question is why did shorts need to hit the stock now? What are they afraid of? Hmmm.
according to some investors here, peak will be much higher than $3.2 at peak. Start with replacement of Herceptin, then add additional indications, then add premium pricing, could be more like $6-10BB at peak.
as did I, this shyte is really getting OLD. Management is enabling this through insider selling and focus on personal/exec/insider wealth creation over shareholders.
I agree, I am tempted to load up on call options after these desperate attempts to smear ARNA, although I was very angry about the rat cancer study blindside after asking them a very specific question regarding animal safety studies before the information came out, but I am over it now, just get the price up!
IMGN cant get lift off. BB's buying more SGEN. IMGN needs a respected large investor, activist, or insider buying (sure), something to boost confidence, or remove weak leadership and unleash the full value!